Literature DB >> 20196792

Pregnancy registries: differences, similarities, and possible harmonization.

Torbjörn Tomson1, Dina Battino, John Craig, Sonia Hernandez-Diaz, Lewis B Holmes, Dick Lindhout, Jim Morrow, Jacqueline French.   

Abstract

Epilepsy and pregnancy registries have been operational for more than 10 years, have accrued considerable experience, and collected an impressive amount of data. As findings have been published, it has become important to understand how observations from the different registries are comparable, especially since their methodologies differ somewhat. In September 2008, representatives of the UK Epilepsy and Pregnancy Register, the North American AED Pregnancy Registry (NAAPR), and the European and International Registry of Antiepileptic Drugs in Pregnancy (EURAP) met for a workshop. Their objectives were to exchange information on their methodologies and to discuss areas where harmonization might be possible. This report summarizes these discussions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20196792     DOI: 10.1111/j.1528-1167.2010.02525.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Prescribing without evidence - pregnancy.

Authors:  Simon H L Thomas; Laura M Yates
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

2.  Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project.

Authors:  David W Loring; Daniel H Lowenstein; Nicholas M Barbaro; Brandy E Fureman; Joanne Odenkirchen; Margaret P Jacobs; Joan K Austin; Dennis J Dlugos; Jacqueline A French; William Davis Gaillard; Bruce P Hermann; Dale C Hesdorffer; Steven N Roper; Anne C Van Cott; Stacie Grinnon; Alexandra Stout
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

3.  Managing epilepsy during pregnancy: assessing risk and optimizing care.

Authors:  Kaarkuzhali Babu Krishnamurthy
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

4.  The International League Against Epilepsy at the threshold of its second century: year 1.

Authors:  Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Gary W Mathern
Journal:  Epilepsia       Date:  2011-01       Impact factor: 5.864

Review 5.  Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.

Authors:  Bruna Nucera; Francesco Brigo; Eugen Trinka; Gudrun Kalss
Journal:  Ther Adv Neurol Disord       Date:  2022-06-11       Impact factor: 6.430

Review 6.  Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.

Authors:  Gali Pariente; Tom Leibson; Talya Shulman; Thomasin Adams-Webber; Eran Barzilay; Irena Nulman
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

Review 7.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

Review 8.  Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.

Authors:  Yusuf Cem Kaplan; Omer Demir
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

9.  Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.

Authors:  Qing-Yi Zeng; Tian-Tian Fan; Pan Zhu; Ru-Qian He; Yi-Xin Bao; Rong-Yuan Zheng; Hui-Qin Xu
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: Obstetric complications and fetal malformation outcomes.

Authors:  Chang Ching Yeh; Eric C Lussier; Yi-Ting Sun; Tzuo-Yun Lan; Hsiang-Yu Yu; Tung-Yao Chang
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.